Real-World Evidence (RWE)

Shifting the Paradigm to Pragmatic Evidence Generation

FDA Issues Draft Guidance Recognizing the Role of Real-World Evidence in Learning More about Populations Underrepresented in Clinical Trials for Drugs and Biological Products

The Future of Diversity in Clinical Trials: Real-World Evidence

Podcast Q&A: Designing Causal Inference Studies Using Real-World Data

Podcast Q&A: Evidence Generation Planning

Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

ウェビナー

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

ウェビナー

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

ウェビナー

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

ウェビナー

RWE reality check: Routine patient health records and regulatory requirements

ウェビナー

"S" Stands for Systematic: Demystifying the Systematic Literature Review

ウェビナー

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

ウェビナー

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

ウェビナー

Insights from the 2024 Salary Survey Report by HealthEconomics.com

ウェビナー

Beyond Accelerated Approvals: External Control Arms

ウェビナー

Delphi Panels: What Are They Good For?

ウェビナー

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

ウェビナー

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

ウェビナー

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

ウェビナー

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

ウェビナー

Synthesise RWE and AI. Transform patient-driven healthcare

ウェビナー

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

ウェビナー

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

ウェビナー

How to assess the quality of AI output when structuring unstructured medical data

ウェビナー

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

ウェビナー

Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help

ウェビナー

How to Supercharge Real World Evidence Generation in Phase IV Trials

ウェビナー

Keeping pace with the evolving global landscape in vaccine development

ウェビナー

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

ウェビナー

Designing Causal Inference Studies Using Real-World Data

ウェビナー

Social Media Data: Opportunities and Insights for Clinical Research

ウェビナー

The Future of Real-World Evidence: Pharma's Next Moves, Upcoming Webinar Hosted by Xtalks

ウェビナー

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

ウェビナー

An Introduction to Infectious Disease Modeling

ウェビナー

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

ウェビナー

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

ウェビナー

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

ウェビナー

Using Real-World Data to Explore and Demonstrate Comparative Effectiveness

ウェビナー

Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

ウェビナー

FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation

ウェビナー

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

ウェビナー

Cracking the Code: When and How to Validate ICD Algorithms for RWE

ウェビナー

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

ウェビナー

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

ウェビナー

Cutting Edge Conversations: Addressing Orphan and Rare Diseases

ウェビナー

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

ウェビナー

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

ウェビナー

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

ウェビナー

Value-Based Agreements - Are We Going to See More or Less of Them?

ウェビナー

Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

ウェビナー

Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible

ウェビナー

Overcoming Clinical Research Challenges: Analyzing EHR Data to Replicate Clinical Trials and Construct External Control Arms

ウェビナー

The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations

ウェビナー

Real World Evidence for COVID-19: Making an impact now and into the future

ポッドキャスト

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap

ポッドキャスト

INsights & OUTcomes with Mark Larkin

ポッドキャスト

INsights & OUTcomes with Radek Wasiak

ポッドキャスト

Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

ポッドキャスト

INsights & OUTcomes with Matt McLoughlin

ポッドキャスト

Podcast Q&A: Patient-Centered Real-World Evidence in Rare Diseases

ポッドキャスト

Podcast Q&A: Real-World Evidence Generation with Disease Registries

ポッドキャスト

Podcast Q&A: Clinical Outcome Assessment (COA) Translations

ポッドキャスト

The Future of Diversity in Clinical Trials: Real-World Evidence

ポッドキャスト

Podcast Q&A: Improving the Representativeness of Research

ポッドキャスト

Podcast Q&A: Literature Reviews and Global Value Dossiers

ポッドキャスト

Podcast Q&A: Platforms and Models for Payer Insights and Evidence Generation

ポッドキャスト

Podcast Q&A: Evidence Generation Planning

ポッドキャスト

Algorithms for Real World Evidence

ポッドキャスト

Podcast Q&A: Real-World Evidence and Neonatal Outcomes

デモを見る

現代のライフサイエンスを支えるデジタル基盤

プロバイダー、ワークフロー、承認、コンプライアンス、データ、支出を一元管理できるインテリジェントなプラットフォームをご紹介します。複雑なプロジェクトをより迅速に、高い可視性と管理体制のもとで推進することが可能です。